Atlas FDA

MEDSTONE STS(TM) EXTRACORPOREAL SHOCK WAVE LITHOTR

FDA premarket approval P870015/S021 · decided 1995-09-15

Approval details

PMA number
P870015
Supplement
S021
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
MEDSTONE STS(TM) EXTRACORPOREAL SHOCK WAVE LITHOTR
Generic name
Lithotriptor, extracorporeal shock-wave, urological
Applicant
Medstone Intl., Inc.
Date received
1995-07-13
Decision date
1995-09-15
Days to decision
64 days
Decision code
APRL
Product code
LNS
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Aliso Viejo, CA
Statement
APPROVAL FOR THE FOLLOWING MODIFICATIONS:USE OF ALTERNATE ULTRASOUND IMAGING UNIT; USE OF ALTERNATE DIGITIZER PAD; MODIFICATION OF SYSTEM SOFTWARE TO VERSION 7.10; AND REVISIONS TO SYSTEMS USER'S MANUAL

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
MEDSTONE, UROPRO 2000, TOMOGRAPHIC OPTION (K013620)Medstone Intl., Inc.2002-01-22
STS-T LITHOTRIPTER, MODEL STS-T (K010900)Medstone Intl., Inc.2001-04-05
STS(TM) FLUOROSCOPIC IMAGING MODULE (K905278)Medstone Intl., Inc.1991-02-04